In-Licensing, Distribution and Commercial Collaborations
Neopharm Group is positioned as the partner-of-choice and one-stop-shop for the multinational pharmaceutical industry. Major scientific and healthcare corporations turn to us when seeking to enter or expend their business in the Israeli market.
Neopharm actively searches in-licensing, distribution, acquisition and commercial collaborations opportunities for the marketing and distribution of high-end products in Israel. These opportunities reinforce Neopharm’s market presence and leadership position in the Israeli market in three main categories:
- Prescription medications, including: innovative pharmaceuticals, biological products and vaccines (either in the clinical development or commercial stages).
- Healthcare products, including: consumer healthcare, OTC, dietary supplements, medical and health foods, dermo- cosmetics, and more.
- Medical equipment, life science and diagnostics equipment.
With over 70 years of marketing and sales experience in a large number of therapeutic areas and activities, at Neopharm Group, we specialize in conducting a quick assessment process and providing our partners with meaningful medical insights and market research.
Neopharm Group marketing, medical and commercial activity is spread across multiple therapeutic areas and market segments. We are always interested in opportunities for all initiatives concerning our current areas and activities as well as other exciting opportunities beyond our current offerings.
Corporate Development/M&A
Having developed into one of the leading pharmaceutical and consumer healthcare companies in Israel, Neopharm Group’s strategic focus is to expand into new markets and synergetic activities. We achieve this goal by leveraging our industry and market expertise, existing financial resources, powerful operational network, as well as our strong relationships with senior management of leading international pharmaceutical and consumer healthcare organizations. In pursuing this strategy, we at Neopharm Group actively consider and pursue acquisitions and entrepreneurship business initiatives.
International: we actively consider acquisitions of pharmaceutical and consumer healthcare companies that enable us to build sales and marketing platforms in United States, Europe and other regions.
Within Israel: we actively consider acquisitions of pharmaceutical and consumer healthcare companies which enable us to expand our market presence and leadership position in the Israeli healthcare market, aiming to reinforce our existing structure and vast product portfolio.
What we offer:
- Best-in-class platform in Israel for marketing and sales of groundbreaking pharmaceuticals, biological, medical and scientific equipment, first-class home care products and consumer healthcare products.
- In-house, state-of-the-art logistics and wholesaling capabilities. Neopharm Group is the only Israeli healthcare distributor affiliated with a multinational healthcare distributor (Alloga/Alliance-Boots).
- A unique partner-of-choice heritage and “shared interests” approach. We do our utmost to preserve our relations with our partners and customers, resulting in our continuous success in the Israeli market. We currently offer the principle platform in Israel for marketing pharmaceutical products.
- We provide our partners with a variety of added-value services that offer benefits above and beyond the scope of the Israeli market.
- Access to Israeli KOLs in various medical fields including marketing and medical surveys and insights.
- Professional sales and application specialists including professional maintenance support for all our medical and life science products.
- A thorough understanding of all the regulatory requirements of the Israeli Ministry of Health.
- Commitment to high ethical standards.
- Commitment to establish a quality system compliant with regulatory requirements that will enable all activities with impact on product quality to be performed in order to assure the product’s quality, efficacy and safety.
- Success in achieving reimbursement. In fact, ALL of Neopharm group’s promoted prescription products are reimbursed by the Israeli National Health Basket.
- Proven ability to venture into new medical fields swiftly and successfully.
- Success in achieving and maintaining leading market share.
- High investment in our employees which enables us to attract and maintain the best professionals in Israel and to establish a corporate environment characterized by the highest level of professionalism and performance.
- Excellent understanding of the Israeli way of conducting business.
